These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1924952)

  • 21. Midterm outcome of patients with asymptomatic restenosis after coronary balloon angioplasty.
    Hernández RA; Macaya C; Iñiguez A; Alfonso F; Goicolea J; Fernandez-Ortiz A; Zarco P
    J Am Coll Cardiol; 1992 Jun; 19(7):1402-9. PubMed ID: 1593031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exercise-induced ST-segment depression in patients without restenosis after coronary angioplasty. Relation to preprocedural impaired left ventricular function.
    Beregi JP; Bauters C; McFadden EP; Quandalle P; Bertrand ME; Lablanche JM
    Circulation; 1994 Jul; 90(1):148-55. PubMed ID: 8025990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multilesion coronary angioplasty: clinical and angiographic follow-up.
    Vandormael MG; Deligonul U; Kern MJ; Harper M; Presant S; Gibson P; Galan K; Chaitman BR
    J Am Coll Cardiol; 1987 Aug; 10(2):246-52. PubMed ID: 2955019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exercise stress testing before and after successful multivessel percutaneous transluminal coronary angioplasty.
    Chalela WA; Kreling JC; Falcão AM; Hueb W; Moffa PJ; Pereyra PL; Ramires JA
    Braz J Med Biol Res; 2006 Apr; 39(4):475-82. PubMed ID: 16612470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Coronary angioplasty performed at the same time as diagnostic coronarography].
    Alfonso F; Macaya C; Iñiguez A; Zarco P
    Rev Esp Cardiol; 1989 Dec; 42(10):645-52. PubMed ID: 2623300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of antiplatelet drug use in preventing restenosis following percutaneous transluminal coronary angioplasty.
    Cox JL; Gotlieb AI
    Can J Cardiol; 1988 May; 4(4):201-10. PubMed ID: 2456140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon coronary angioplasty.
    Urban P; Buller N; Fox K; Shapiro L; Bayliss J; Rickards A
    Br Heart J; 1988 Dec; 60(6):485-8. PubMed ID: 2975949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of platelet size before coronary angioplasty on subsequent restenosis.
    Smyth DW; Martin JF; Michalis L; Bucknall CA; Jewitt DE
    Eur J Clin Invest; 1993 Jun; 23(6):361-7. PubMed ID: 8344336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Restenosis, the Achilles heel of coronary angioplasty].
    Macaya C
    An Med Interna; 1991 Jan; 8(1):1-3. PubMed ID: 1912149
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty.
    Ellis SG; Roubin GS; Wilentz J; Douglas JS; King SB
    Am Heart J; 1989 Apr; 117(4):777-82. PubMed ID: 2522716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restenosis following coronary angioplasty.
    Karas SP; Santoian EC; Gravanis MB
    Clin Cardiol; 1991 Oct; 14(10):791-801. PubMed ID: 1954687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliability of exercise-induced ST segment changes to detect restenosis 3 months after coronary angioplasty: significance of the appearance in other leads.
    Michaelides AP; Dilaveris PE; Psomadaki ZD; Aggelakas S; Stefanadis C; Cokkinos D; Gialafos J; Toutouzas PK
    Am Heart J; 1998 Jan; 135(1):74-81. PubMed ID: 9453524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restenosis after coronary angioplasty.
    Anderson HV; Vignale SJ; Benedict CR; Willerson JT
    J Interv Cardiol; 1993 Sep; 6(3):187-202. PubMed ID: 10151016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reliability of the exercise-induced ST-segment changes to detect restenosis three months after coronary angioplasty: significance of the appearance in other leads.
    Michaelides AP; Dilaveris PE; Psomadaki ZD; Aggelakas S; Stefanadis C; Cokkinos D; Gialafos J; Toutouzas PK
    Am Heart J; 1998 Mar; 135(3):449-56. PubMed ID: 9506331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of restenosis after coronary angioplasty: a pharmacological approach.
    Meier B
    Eur Heart J; 1989 Dec; 10 Suppl G():64-8. PubMed ID: 2697565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Has collateral blood flow any effect on restenosis rate? Our experience.
    Li Y; Sun Y; Liu T; Liu P; Li G; Zhang Y
    Front Neurol; 2024; 15():1360161. PubMed ID: 38476194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation factors affecting the first recurrence of coronary artery disease in patients undergone angioplasty using cox survival model.
    Nasseryan J; Hajizadeh E; Rasekhi A; Ahangar H
    Med J Islam Repub Iran; 2016; 30():441. PubMed ID: 28210606
    [No Abstract]   [Full Text] [Related]  

  • 38. Erratum to: P2 receptors in atherosclerosis and postangioplasty restenosis.
    Seye CI; Kong Q; Yu N; Gonzalez FA; Erb L; Weisman GA
    Purinergic Signal; 2015 Sep; 11(3):409. PubMed ID: 26223406
    [No Abstract]   [Full Text] [Related]  

  • 39. Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects.
    Mehta JL
    Clin Cardiol; 1998 Dec; 21(12):879-84. PubMed ID: 9853178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II).
    Herrman JP; Hermans WR; Vos J; Serruys PW
    Drugs; 1993 Aug; 46(2):249-62. PubMed ID: 7691514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.